Clinical Trials Sponsored by Chiesi Italia
Total 7397 results
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Terminated
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
CANDONI ANNAGruppo Italiano Trapianto di Midollo OsseoCompletedPhiladelphia Positive Acute Lymphoblastic Leukemia | SCTItaly
-
Chiesi Farmaceutici S.p.A.RecruitingChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Chiesi Farmaceutici S.p.A.RecruitingChronic Obstructive Pulmonary DiseaseBulgaria, United States, Argentina, Austria, Bosnia and Herzegovina, Chile, Croatia, Czechia, Estonia, Germany, Greece, Hungary, Israel, Latvia, Mexico, Netherlands, New Zealand, North Macedonia, Poland, Romania, Russian Federation and more
-
Chiesi Farmaceutici S.p.A.RecruitingCOPD | COPD ExacerbationUnited States, Bulgaria, Hungary, Poland, Argentina, Czechia, Mexico, Canada, Puerto Rico, Romania
-
Chiesi Farmaceutici S.p.A.Active, not recruitingIdiopathic Pulmonary FibrosisNorth Macedonia, Ukraine, United Kingdom
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Active, not recruiting
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedAsthma | Chronic Obstructive Pulmonary Disease (COPD)United States
-
Chiesi Farmaceutici S.p.A.CompletedMucociliary ClearanceUnited Kingdom
-
Chiesi Farmaceutici S.p.A.TerminatedNeonatal Opioid Withdrawal SyndromeUnited States
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedSevere Combined Immunodeficiency | Adenosine Deaminase DeficiencyUnited States
-
Chiesi Farmaceutici S.p.A.Active, not recruitingFabry DiseaseUnited States, Netherlands, Australia, Hungary, United Kingdom, Canada, Czechia, Finland, France, Italy, Norway, Slovenia, Spain
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseBulgaria
-
Chiesi Canada CorpNo longer availablePantothenate Kinase-Associated Neurodegeneration
-
Chiesi Farmaceutici S.p.A.WithdrawnRestoration of Function to CVADsUnited States, Bulgaria, Hungary
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseHungary
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseHungary
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseFrance
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseItaly, Germany, Hungary
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedRespiratory Distress Syndrome, NewbornUnited States
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedAsthmaSpain, Austria, Italy, Poland
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedCystic FibrosisCzechia, Moldova, Republic of, Slovakia
-
Chiesi Farmaceutici S.p.A.CompletedCystic FibrosisUkraine, France, Poland
-
Chiesi Farmaceutici S.p.A.CompletedA Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001 (CHF6001Ext)Chronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary Disease | AsthmaUnited Kingdom
-
Chiesi Farmaceutici S.p.A.TerminatedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseBelgium, Hungary
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed
-
Chiesi Farmaceutici S.p.A.Completed